Science

Amino acid boosts last-resort antibiotic's effectiveness

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 29/10/2026, 13:10:24 UTC.

Briefings

A recent study suggests a specific amino acid may improve the efficacy of colistin, a critical last-resort antibiotic against resistant infections. The World Health Organization warns that rising rates of colistin resistance are increasing global mortality, creating an urgent need for new therapeutic strategies. This research aims to provide a potential solution to the growing crisis of antibiotic resistance.

Key points

• A specific amino acid was identified as a potential booster for colistin's effectiveness against resistant infections.
• Colistin resistance rates are rising globally, leading to increased mortality and a need for new treatments.

Context

The World Health Organization warns that antibiotic resistance is a major global health threat, with millions of deaths annually. Colistin is a critical last-resort antibiotic used when other treatments fail, but its resistance rates are also increasing, putting patients at greater risk.

Limitations

The evidence is limited to a single study published in October 2026. The specific amino acid and its exact mechanism of action remain to be fully characterized. The study does not provide data on long-term efficacy or clinical trial results.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 29/10/2026, 13:19:47 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeicd7365aaxtkrgvvxdlyulaxxp7lsrrpdrfxljkha2wsmu3dd5o5y